Synthesis and anti-leukemic activity of alkyl-1-(.beta.-D-ribofu

Organic compounds -- part of the class 532-570 series – Organic compounds – Carbohydrates or derivatives

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C07H 19056

Patent

active

049259300

ABSTRACT:
A novel class of alkyl-1-(.beta.-D-ribofuranosyl)[1,2,4]triazole-3-carboximidates of the formula: ##STR1## wherein R.sub.1 is methyl or ethyl and R.sub.2 is .beta.-D-ribofuranosyl, are useful as anti-leukemic agents.

REFERENCES:
patent: Re29835 (1978-11-01), Witkowski et al.
patent: 3798209 (1978-11-01), Witkowski et al.
patent: 3897415 (1975-07-01), Robins et al.
patent: 3948885 (1976-04-01), Witkowski et al.
patent: 3968103 (1976-07-01), Robins et al.
patent: 3976545 (1976-08-01), Witkowski et al.
patent: 3984396 (1976-10-01), Witkowski et al.
patent: 3991078 (1976-11-01), Witkowski et al.
patent: 4138547 (1979-02-01), Christensen et al.
patent: 4211771 (1980-07-01), Witkowski et al.
Ganesh D. Kini, et al., J. Med. Chem., 32, 1447 (1989).
Witkowski et al., J. Med. Chem., 16, 935 (1973).
Riley et al., J. Heterocyclic Chem., 34, 955 (1987).

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Synthesis and anti-leukemic activity of alkyl-1-(.beta.-D-ribofu does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Synthesis and anti-leukemic activity of alkyl-1-(.beta.-D-ribofu, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Synthesis and anti-leukemic activity of alkyl-1-(.beta.-D-ribofu will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-622246

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.